San Clemente-based ReShape Lifesciences Inc. (Nasdaq: RSLS) raised nearly $1.5 million from several institutional investors for the purchase of 374,572 shares of its common stock at $3.92 per share, according to filings with the Securities and Exchange Commission.
Richard Gannotta was named chief executive of UCI Health, the clinical, medical education and research arm of the University of California-Irvine.
Baby Items Get Hospital Nod; Additional Colors
Balancing motherhood and a career isn’t just a dream when it comes to Lil ‘O’ Blossom founder and Chief Executive Lorie Collins.
Tennis Deal Gets Masimo Into Fitness Wearables
Irvine-based medical device maker Inari Medical Inc. received Food and Drug Administration clearance for the FlowTriever System, which is used to treat pulmonary embolism, a condition in which one or more arteries in the lungs are blocked by a blood clot.
HEALTHCARE: To hire, grow consumer line, clinical programs
Eighteen-month-old Aivita Biomedical is in pretty good shape for a newly formed company.
Following a letter from activist investors Appaloosa LP in Miami, Fla., and New York-based Senator Investment Group LP to Allergan PLC’s board of directors that recommends changes—including separating the chief executive and chairman roles—billionaire Carl Icahn also threw his hat in the game, taking an undisclosed position in Allergan, according to Bloomberg.
ChromaDex Corp. (Nasdaq: CDXC) named Lisa Bratkovich chief marketing officer, effective June 4.
Fujifilm Corp. President Kenji Sukeno said the company completed its earlier-announced acquisition of two cell culture media businesses, Irvine Scientific Sales Company Inc. in Santa Ana and Is Japan Co. Ltd. in Tokyo, from Japanese oil and metal conglomerate JXTG Holdings.
HEALTHCARE: With Sanpower as owner, plans China facilities
Dendreon Pharmaceuticals LLC is emerging from last year’s sale, its second in three years, stronger than ever, with near-term international expansion in sight. Chief Executive James “Jim” Caggiano said its parent company, Nanjing-based Chinese conglomerate Sanpower Group Co. Ltd., will set up manufacturing facilities in Hong Kong and China.
Irvine-based Sabra Health Care REIT Inc. (Nasdaq: SBRA) completed the previously announced sale of 12 facilities leased to Genesis Healthcare Inc. (NYSE: GEN) for $134 million.
Hancock Jaffe Labs Revises IPO Numbers
Orange County’s reputation as one of the country’s top medical device hubs is well-deserved, and its cardiovascular disease-focused device makers are buzzing with activity.
Annette Walker to Head City of Hope OC in July
The uniqueness of City of Hope’s new cancer center in Orange County speaks for itself—the project certainly caught Annette Walker’s attention.
Evolus Inc. (Nasdaq: EOLS) appointed Lauren Silvernail as chief financial officer and executive vice president of corporate development.
British engineering firm Smiths Group plc (LON: SMIN) confirmed it is in “very early stage discussions about a potential merger of its medical division with ICU Medical Inc. (Nasdaq: ICUI),” according to a company press release.
Platform Founded in OC, Backed by Investor Legend
A New York-based startup with deep ties to Orange County raised an $8 million seed round led by Stamford, Conn.-based Point72 Ventures, with participation from Quiet Capital, Struck Capital, Core Innovation Capital and other venture and strategic investors.
Model Increases Skilled Nursing Reimbursement
Proposed payment updates by the Centers for Medicare and Medicaid Services have buoyed skilled nursing, an industry that’s taken a hit from lowered reimbursements.
HEALTHCARE: Positive momentum; foresees FDA OK
The past couple of years have been difficult for Endologix Inc. (Nasdaq: ELGX), but conditions appear to be improving at the Irvine-based medical device maker, with a repositioned portfolio and a new leader at the helm.
Brings on Landmark To Provide Home-Based Care
Care is moving homeward, driven by patient preference and more importantly, cost.
It’s Top Online Seller; Seeks Larger Headquarters
“First, I am not Bob,” said Bob’s Watches owner Paul Altieri.
Irvine-based Evolus Inc.’s stock (Nasdaq: EOLS) have taken a rollercoaster ride this week. Shares earlier buoyed by news of its new chief executive dove today when it gave updates related to the regulatory progress on the pending approval of its drug candidate DWP-450.
HEALTHCARE: Wants to make drug big-brand contender
Wall Street is pleased with Evolus Inc.’s (Nasdaq: EOLS) new president and chief executive, David Moatazedi, as shares of the company shot up more than 40% since the news broke on May 7.
Seeks $2 Million, Plans To Add Blockchain
The cannabis industry is booming, generating $9.7 billion in North America last year, up 33% over 2016, according to a report by Arcview Market Research and BDS Analytics that predicts the market will reach $24.5 billion in sales by 2021.
First Commercially Available Treatment
Edwards Lifesciences Corp. (NYSE: EW) continues pushing the envelope on cutting-edge transcatheter cardiovascular therapies, recently receiving European CE Mark approval for the Cardioband Tricuspid Valve Reconstruction System for the treatment of tricuspid regurgitation.
HEALTHCARE: 20-plus years later, device co. plans for FDA nod
Irvine-based TherOx Inc. secured debt financing this month from existing investor Zoll Medical Corp. to support a limited launch of its SuperSaturated Oxygen therapy system upon receipt of Food and Drug Administration approval.
OCTANe Forum Soon; Presents Eight
Aliso Viejo-based accelerator OCTANe will showcase eight LaunchPad companies at its annual Technology Innovation Forum at the Newport Beach Hotel & Spa from May 31 to June 1.
Allergan Plc named Carrie Strom as senior vice president of U.S. Medical Aesthetics, reporting to Chief Commercial Officer Bill Meury.
Evolus Inc. named David Moatazedi president and chief executive. He comes from Allergan plc, where he was most recently senior vice president of U.S. medical aesthetics.
HEALTHCARE: Diagnostic test shorter pathway to sales
“All disease begins in the gut,” wrote Greek physician Hippocrates. There’s a lot of truth in the claim; studies have shown that the health of the gastrointestinal system impacts not only the entire body, but also brain and emotional health.
Increases Lab Space; Adds Three Customers
Avid Bioservices Inc. (Nasdaq: CDMO) is moving on. It’s bid farewell to its days as immuno-oncology drug developer, including divesting its lead immune-oncology drug, and is growing its position as a pure-play biologics manufacturing business.
Online Community To Grow Charitable Giving
While nonprofit organizations aren’t revenue-driven, they’re businesses in the sense that their progress can be measured—more precisely, how much money they raise from donors to support their visions. Irvine-based Givsum Inc., whose platform consolidates elements of philanthropy onto a single platform, is building a community “to solve the big problems of the world,” said Chief Strategy Officer and General Counsel Robert Kollar.
Allergan PLC Chief Executive Brent Saunders told investors on Monday that the company is evaluating a range of strategic options, including “splitting the company.”
Allergan Plc posted first quarter earnings that beat analyst estimates and raised its revenue guidance for 2018.
Studying Program Effectiveness Using VR
BioCorRx Inc. Chief Executive Brady Granier said the company’s history of treating addiction long predates President Donald Trump’s public health emergency declaration over opioid addiction.
Technology Used For Mitral Valve Repair
The next frontier in the interventional cardiology world is transcatheter mitral valve repair and replacement.
HEALTHCARE: Care close to patients, tech in the center
Were St. Louis, Mo.-based Ascension Healthcare and Renton, Wash.-based Providence St. Joseph Health to merge, the health systems would be the largest U.S. owner of hospitals, with 191 across 27 states and the District of Columbia between them—topping Nashville-based HCA Healthcare Inc., which has 177 hospitals in 20 states and the United Kingdom.
Children’s Hospital of Orange County plans to open an autism center at 170 S. Main St. in Orange in early 2019.
ChromaDex Corp. (Nasdaq: CDXC) said Chief Executive Frank Jaksch will become executive chairman and the company’s current president and chief operating officer, Rob Fried, will get Jaksch's role June 22, after the company’s annual meeting.
HEALTHCARE: Grows SoCal presence with M&A
Vantari Genetics Chief Executive Nick Arroyo said there are only two ways to grow the private company, organically through internal growth or through mergers and acquisitions.
Will Tap Family Office Networks
Orange County technology and life science accelerator OCTANe has partnered with New York-based Small Cap Nation, a financial-media content distribution platform that develops news and information through video, social media, articles, broadcast and newsletters. It’s focused on the small-cap sector.
REAL ESTATE: Disposition, more life science properties
HCP Inc.’s (NYSE: HCP) repositioning has been a bumpy one over the course of the past 18 months.
Offers Telemedicine and Diagnostics Services
Mental health is a hot issue, particularly in light of the country’s declared opioid epidemic, and Mission Viejo-based MYnd Analytics Inc. (Nasdaq: MYND) appears to be on the right track with its diagnostics platform and telemedicine.
To Offer Short-Term Lease Flexibility
There’s no turning back from shopping online. E-commerce totaled $453 billion last year, representing 13% of total retail sales and up 16% year-over-year, according to a U.S. Commerce Department report.
“It’s How You Carry It,” The Company Advises
Tony Zentil spent 17 years managing Oakley’s accessories division—helping to grow the category from $15 million to $100 million.
Hires Planned For Home-Care Frontier
Revenue from Irvine-based Masimo Corp.’s noninvasive patient monitoring technologies grew last year by 15% to $798.1 million, and Chief Executive Joe Kiani said the company plans to grow its new telehealth initiative.
To Provide Blockchain-Based Cybersecurity Solution
Take away the hype around digital cryptocurrency—some claim it’s bogus, given that the virtual coins aren’t backed by anything but the value people give them—and what’s left is blockchain technology.
HEALTHCARE: Launched IvyGene; to expand Irvine HQ
Irvine-based Laboratory for Advanced Medicine Inc. isn’t pursuing a magic-bullet immunotherapy drug to cure all cancers yet, but it sure is in growth mode.
Partners With Apothecary For Full CVS Launch
Innovation Institute, founded five years ago as an incubator to commercialize internal medical innovation by doctors, nurses and other hospital care providers in its six health system-owners network, has done exactly that.
Irvine-based Inari Medical Inc. received $27 million in a series C round to support commercialization.
Irvine-based Axonics Modulation Technologies received a $40.1 million financing comprised of $20.1 million in equity and a $20 million credit facility.
Edwards Gets FDA OK; Masimo Centers on Remote
Irvine-based device maker Edwards Lifesciences Corp. (NYSE: EW), while best known as one of the pioneers in less-invasive transcatheter heart valves, also has a strong focus in critical-care patient monitoring.